Alopecia and Hirsuties

The 1988 document examines androgenic alopecia and hirsuties, detailing their pathogenesis, such as androgen overproduction by adrenal and ovarian glands, and management strategies. It reports that up to 13% of premenopausal and 37% of postmenopausal women experience male-pattern hair loss, while hirsuties' treatment includes depilatory methods and systemic antiandrogen therapy, which only temporarily halts hair growth. The document highlights the lack of objective studies on antiandrogen therapy for female baldness and the absence of studies on minoxidil's effectiveness at that time. It also emphasizes the importance of a thorough medical evaluation for hirsute women and notes that while various treatments exist, they often do not offer a permanent cure for these conditions.